OPTIMAL TUMOR REDUCTION, PLATINUM SENSITIVITY CHARACTERIZE LONG-TERM OVARIAN CANCER SURVIVAL
A multicenter study led by Tina’s Wish Researcher, Douglas Levine, MD, of MSK shows that women who are long-term survivors of high-grade serous carcinoma ovarian cancer usually have platinum-sensitive disease and undergo optimal tumor reduction surgery.